Neuroradiology: The Surrogate of Gross Neuropathology

Practical Surgical Neuropathology: A Diagnostic Approach

Volumn , Issue , 2010, Pages 47-62

  Wippold, Franz J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857333406     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06982-6.00004-3     Document Type: Chapter

References (57)

1. Huda W., Slone R.M. Analog X-ray imaging. Review of Radiologic Physics 2003, 49-67. Lippincott Williams & Wilkins, Philadelphia. 2nd ed.
2. Huda W., Slone R.M. X-ray production. Review of Radiologic Physics 2003, 16-33. Lippincott Williams & Wilkins, Philadelphia. 2nd ed.
3. Gado M.H., Phelps M.E., Coleman R.E. An extravascular component of contrast enhancement in cranial computed tomography. Part I. The tissue-blood ratio of contrast enhancement. Radiology 1975, 117:589-593.
4. Gado M.H., Phelps M.E., Coleman R.E. An extravascular component of contrast enhancement in cranial computed tomography. Part II. Contrast enhancement and the blood-tissue barrier. Radiology 1975, 117:595-597.
5. Krautmacher C., Willinek W.A., Tschampa H.J., et al. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T-Initial experience. Radiology 2005, 237:1014-1019.
6. Bird C.R., Dean B. Pathology of brain neoplasms. Top Magn Reson Imaging 1989, 1:6-15.
7. Knopp M.V., Runge V.M., Essig M., et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2004, 230:55-64.
8. Lauenstein T.C., Salman K., Morreira R., et al. Nephrogenic systemic fibrosis: center case review. J Magn Reson Imaging 2007, 26:1198-1203.
9. Kanal E., Broome D.R., Martin D.R., Thomsen H.S. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology 2008, 246:11-14.
10. Partain C.L. On the potential causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007, 25:879-880.
11. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol. 2003, 45:169-184.
12. Neil J.J. Measurement of water motion (apparent diffusion) in biological systems. Concept Magn Reson. 1997, 9:385-401.
13. Neil J.J. Diffusion imaging concepts for clinicians. J Magn Reson Imaging 2008, 27:1-7.
14. Castillo M., Mukherji S.K. Diffusion-weighted imaging in the evaluation of intracranial lesions. Semin Ultrasound CT MR 2000, 21:405-416.
15. Provenzale J.M., Mukundan S., Barboriak D.P. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006, 239:632-649.
16. Higano S., Yun X., Kumabe T., et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006, 241:839-846.
17. Murakami R., Sugahara T., Nakamura H., et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007, 243:493-499.
18. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol. 2006, 27:475-487.
19. Al-Okaili R.N., Krejza J., Woo J.H., et al. Intraaxial brain masses: MR imaging-based diagnostic strategy-initial experience. Radiology 2007, 243:539-550.
20. Young R.J., Knopp E.A. Brain MRI: tumor evaluation. J Magn Reson Imaging 2006, 24:709-724.
21. Al-Okaili R.N., Krejza J., Wang S., et al. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006, 26(suppl 1):S173-S189.
22. Inoue T., Ogasawara K., Beppu T., et al. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg. 2005, 107:174-180.
23. Field A.S., Alexander A.L. Diffusion tensor imaging in cerebral tumor diagnosis and therapy. Top Magn Reson Imaging 2004, 15:315-324.
24. Field A.S., Alexander A.L., Wu Y.C., et al. Diffusion tensor eigenvector directional color imaging patterns in the evaluation of cerebral white matter tracts altered by tumor. J Magn Reson Imaging 2004, 20:555-562.
25. Guo A.C., Cummings T.J., Dash R.C., Provenzale J.M. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002, 224:177-183.
26. Kono K., Inoue Y., Nakayama K., et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol. 2001, 22:1081-1088.
27. Gauvain K.M., McKinstry R.C., Mukherjee P., et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol. 2001, 177:449-454.
28. Stadnik T.W., Chaskis C., Michotte A., et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol. 2001, 22:969-976.
29. Krabbe K., Gideon P., Wagn P., et al. MR diffusion imaging of human intracranial tumours. Neuroradiology 1997, 39:483-489.
30. Lu S., Ahn D., Johnson G., Law M., et al. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004, 232:221-228.
31. Pierpaoli C., Jezzard P., Basser P.J., et al. Diffusion tensor MR imaging of the human brain. Radiology 1996, 201:637-648.
32. Jellison B.J., Field A.S., Medow J., et al. Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. AJNR Am J Neuroradiol. 2004, 25:356-369.
33. Melhem E.R., Mori S., Mukundan G., et al. Diffusion tensor MR imaging of the brain and white matter tractography. AJR Am J Roentgenol. 2002, 178:3-16.
34. Roberts T.P., Liu F., Kassner A., et al. Fiber density index correlates with reduced fractional anisotropy in white matter of patients with glioblastoma. AJNR Am J Neuroradiol. 2005, 26:2183-2186.
35. Lazar M., Alexander A.L., Thottakara P.J., et al. White matter reorganization after surgical resection of brain tumors and vascular malformations. AJNR Am J Neuroradiol. 2006, 27:1258-1271.
36. Smith J.S., Cha S., Mayo M.C., et al. Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg. 2005, 103:428-438.
37. Stadlbauer A., Gruber S., Nimsky C., et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 2006, 238:958-969.
38. Sibtain N.A., Howe F.A., Saunders D.E. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol. 2007, 62:109-119.
39. Le Bihan D., Douek P., Argyropoulou M., et al. Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 1993, 5:25-31.
40. Taylor J.S., Tofts P.S., Port R., et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999, 10:903-907.
41. Choyke P.L., Dwyer A.J., Knopp M.V. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003, 17:509-520.
42. Cha S. Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 2004, 15:279-289.
43. Law M., Brodsky J.E., Babb J., et al. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: preliminary results of molecular studies in gliomas with elevated perfusion. J Magn Reson Imaging 2007, 25:1113-1119.
44. Law M., Oh S., Johnson G., et al. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 2006, 58:1099-1107. discussion 1099-1107.
45. Law M., Yang S., Wang H., et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003, 24:1989-1998.
46. Young R., Babb J., Law M., et al. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging 2007, 26:1053-1063.
47. Shin J.H., Lee H.K., Kwun B.D., et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol. 2002, 179:783-789.
48. Hoeffner E.G., Case I., Jain R., et al. Cerebral perfusion CT: technique and clinical applications. Radiology 2004, 231:632-644.
49. Moreno A., de Felipe J., Garcia Sola R., et al. Neuronal and mixed neuronal glial tumors associated to epilepsy. A heterogeneous and related group of tumours. Histol Histopathol. 2001, 16:613-622.
50. Williams K.D., Drayer B.P., Bird C.R. Magnetic resonance imaging in the diagnosis of intracerebral hematoma. BNI Q. 1989, 5:16-23.
51. Runge V.M., Muroff L.R., Jinkins J.R. Central nervous system: review of clinical use of contrast media. Top Magn Reson Imaging 2001, 12:231-263.
52. Watanabe M., Tanaka R., Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992, 34:463-469.
53. Al-Okaili R.N., Krejza J., Wang S., Woo J.H., Melhem E.R. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006, 26(Suppl 1):S173-189.
54. Al-Okaili R.N., Krejza J., Woo J.H., et al. Intraaxial brain masses: MR imaging-based diagnostic strategy-initial experience. Radiology 2007, 243:539-550.
55. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol. 2006, 27:475-487.
56. Inoue T., Ogasawara K., Beppu T., Ogawa A., Kabasawa H. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg. 2005, 107:174-180.
57. Young R.J., Knopp E.A. Brain MRI: tumor evaluation. J Magn Reson Imaging 2006, 24:709-724.